Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$5,670 Mln
Revenue (TTM)
$2,530 Mln
Net Profit (TTM)
$188 Mln
ROE
0.3 %
ROCE
-- %
P/E Ratio
21.9
P/B Ratio
5.6
Industry P/E
--
EV/EBITDA
13.2
Div. Yield
0.6 %
Debt to Equity
0.2
Book Value
$70
EPS
$19
Face value
--
Shares outstanding
13,765,136
CFO
$2,606.13 Mln
EBITDA
$3,054.09 Mln
Net Profit
$1,952.13 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Chemed Corp (CHE)
| -10.8 | -18.4 | -11.3 | -37.0 | -9.5 | -3.3 | 11.1 |
|
BSE Sensex
| -12.4 | -11.4 | -12.2 | -1.5 | 8.6 | 8.6 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Chemed Corp (CHE)
| -19.2 | -9.3 | 14.6 | -3.5 | -0.7 | 21.3 | 55.1 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Chemed Corp (CHE)
|
381.8 | 5,670.0 | 2,530.0 | 265.2 | 14.2 | 25.3 | 21.9 | 5.6 |
| 14.0 | 3,315.2 | 3,125.0 | -262.7 | 0.9 | -313.2 | -- | 20.5 | |
| 53.5 | 2,697.1 | 941.5 | 105.7 | 14.5 | 29.4 | 25.8 | 7.2 | |
| 97.9 | 10,098.8 | 5,935.2 | 566.2 | 18.1 | 25.1 | 18.1 | 4.1 | |
| 23.5 | 5,434.1 | 2,347.6 | 128.4 | 4.9 | 25.2 | 46.7 | 10.0 | |
| 29.1 | 4,649.3 | 5,649.5 | 207.6 | 7.0 | 15.2 | 23.1 | 3.5 | |
| 21.5 | 2,681.6 | 2,122.8 | 22.9 | 1.9 | 0 | 120.4 | 3.6 | |
| 61.9 | 4,818.9 | 2,040.2 | -18.7 | 5.0 | -1.9 | -- | 4.4 | |
| 13.4 | 3,815.1 | 1,163.6 | 78.0 | 26.1 | 15.4 | 49.7 | 6.3 | |
| 200.8 | 12,186.8 | 5,057.8 | 344.0 | 9.2 | 16.9 | 36 | 5.5 |
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates... through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio. Read more
CEO, President & Director
Mr. Kevin J. McNamara
CEO, President & Director
Mr. Kevin J. McNamara
Headquarters
Cincinnati, OH
Website
The share price of Chemed Corp (CHE) is $381.82 (NYSE) as of 19-Mar-2026 14:40 EDT. Chemed Corp (CHE) has given a return of -9.47% in the last 3 years.
The P/E ratio of Chemed Corp (CHE) is 21.92 times as on 13-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
22.57
|
6.11
|
|
2024
|
26.30
|
7.10
|
|
2023
|
32.77
|
8.06
|
|
2022
|
30.78
|
9.62
|
|
2021
|
30.56
|
13.17
|
The 52-week high and low of Chemed Corp (CHE) are Rs 623.61 and Rs 376.20 as of 20-Mar-2026.
Chemed Corp (CHE) has a market capitalisation of $ 5,670 Mln as on 13-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Chemed Corp (CHE), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.